Altamira Therapeutics Ltd. (CYTOF): 6-K filed Apr 30, 2025

Form type

6-K

Filing date

Apr 30, 2025

Accession number

0001213900-25-037097

Filer

Altamira Therapeutics Ltd. (CIK 1601936)